A SPAC I in a proxy filing set a March 1 date for shareholders to vote on a proposed merger with fertility company NewGenIvf.
The target is a full-service fertility services provider in Asia. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan.
Announced a year ago today, the transaction values NewGen at an implied enterprise value of approximately $50 million.
Jun He Law Offices is serving as legal advisor to NewGen. Loeb & Loeb, Haiwen & Partners, DFDL (Thailand), Kalikova & Associates law firm and Ogier are serving as legal advisors to A SPAC I.
A SPAC I initially raised $60 million in February 2022 to target the technology and e-commerce industries with a focus in Asia and on companies with an enterprise value of between $250 million and $600 million, excluding any company in China. Read more.
